253 related articles for article (PubMed ID: 23099335)
1. The coagulopathy and thrombotic risk associated with L-asparaginase treatment in adults with acute lymphoblastic leukaemia.
Truelove E; Fielding AK; Hunt BJ
Leukemia; 2013 Mar; 27(3):553-9. PubMed ID: 23099335
[TBL] [Abstract][Full Text] [Related]
2. Thrombosis associated with L-asparaginase therapy and low fibrinogen levels in adult acute lymphoblastic leukemia.
Beinart G; Damon L
Am J Hematol; 2004 Dec; 77(4):331-5. PubMed ID: 15551293
[TBL] [Abstract][Full Text] [Related]
3. Changes in antithrombin and fibrinogen levels during induction chemotherapy with L-asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma. Use of supportive coagulation therapy and clinical outcome: the CAPELAL study.
Hunault-Berger M; Chevallier P; Delain M; Bulabois CE; Bologna S; Bernard M; Lafon I; Cornillon J; Maakaroun A; Tizon A; Padrazzi B; Ifrah N; Gruel Y;
Haematologica; 2008 Oct; 93(10):1488-94. PubMed ID: 18728028
[TBL] [Abstract][Full Text] [Related]
4. Incidence and management of asparaginase-associated adverse events in patients with acute lymphoblastic leukemia.
Earl M
Clin Adv Hematol Oncol; 2009 Sep; 7(9):600-6. PubMed ID: 20020672
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy induces enhanced procoagulant activity through phosphatidylserine exposure in acute lymphoblastic leukemia.
Dong X; Shi J; Zhou J; Chen X; Jin Y; Zhang X; Li X; Dai H; Wang J
Thromb Res; 2013 Nov; 132(5):614-20. PubMed ID: 24074703
[TBL] [Abstract][Full Text] [Related]
6. A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase: results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) Study.
Mitchell LG; Andrew M; Hanna K; Abshire T; Halton J; Anderson R; Cherrick I; Desai S; Mahoney D; McCuster P; Wu J; Dahl G; Chait P; de Veber G; Lee KJ; Mikulis D; Ginsberg J; Way C;
Cancer; 2003 Jan; 97(2):508-16. PubMed ID: 12518376
[TBL] [Abstract][Full Text] [Related]
7. Different profile of thrombin generation in children with acute lymphoblastic leukaemia treated with native or pegylated asparaginase: A cohort study.
Rozen L; Noubouossie D; Dedeken L; Huybrechts S; Lê PQ; Ferster A; Demulder A
Pediatr Blood Cancer; 2017 Feb; 64(2):294-301. PubMed ID: 27605400
[TBL] [Abstract][Full Text] [Related]
8. Cerebral venous thrombosis in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma during induction chemotherapy with l-asparaginase: The GRAALL experience.
Couturier MA; Huguet F; Chevallier P; Suarez F; Thomas X; Escoffre-Barbe M; Cacheux V; Pignon JM; Bonmati C; Sanhes L; Bories P; Daguindau E; Dorvaux V; Reman O; Frayfer J; Orvain C; Lhéritier V; Ifrah N; Dombret H; Hunault-Berger M; Tanguy-Schmidt A
Am J Hematol; 2015 Nov; 90(11):986-91. PubMed ID: 26214580
[TBL] [Abstract][Full Text] [Related]
9. [Coagulation disorders during treatment with l-asparaginase preparations].
Dobaczewski G
Wiad Lek; 1998; 51 Suppl 4():227-32. PubMed ID: 10731973
[TBL] [Abstract][Full Text] [Related]
10. Thrombosis related to the use of L-asparaginase in adults with acute lymphoblastic leukemia: a need to consider coagulation monitoring and clotting factor replacement.
Alberts SR; Bretscher M; Wiltsie JC; O'Neill BP; Mokri B; Witzig TE
Leuk Lymphoma; 1999 Feb; 32(5-6):489-96. PubMed ID: 10048421
[TBL] [Abstract][Full Text] [Related]
11. A regimen for antithrombin III substitution in patients with acute lymphoblastic leukemia under treatment with L-asparaginase.
Mattioli Belmonte M; Gugliotta L; Delvos U; Catani L; Vianelli N; Cascione ML; Belardinelli AR; Mottola L; Tura S
Haematologica; 1991; 76(3):209-14. PubMed ID: 1743591
[TBL] [Abstract][Full Text] [Related]
12. [Superior sagittal sinus thrombosis following L-asparaginase therapy of acute lymphoblastic leukemia].
Watanabe I; Sakai I; Matsumoto I
Rinsho Ketsueki; 1992 Mar; 33(3):343-8. PubMed ID: 1578639
[TBL] [Abstract][Full Text] [Related]
13. Antithrombin III infusion suppresses the hypercoagulable state in adult acute lymphoblastic leukaemia patients treated with a low dose of Escherichia coli L-asparaginase. A GIMEMA study.
Mazzucconi MG; Gugliotta L; Leone G; Dragoni F; Belmonte MM; De Stefano V; Chistolini A; Tura S; Mandelli F
Blood Coagul Fibrinolysis; 1994 Feb; 5(1):23-8. PubMed ID: 7514043
[TBL] [Abstract][Full Text] [Related]
14. [Fulminant hepatitis possibly caused by L-asparaginase during induction chemotherapy in a patient with acute lymphoblastic leukemia].
Tsutsui M; Koike M; Komatsu N
Rinsho Ketsueki; 2012 May; 53(5):531-4. PubMed ID: 22728556
[TBL] [Abstract][Full Text] [Related]
15. L-asparaginase induced intracranial haemorrhage in acute lymphoblastic leukemia.
Lim HL; Teo CP; Wong K; Kueh YK
Singapore Med J; 1998 Feb; 39(2):76-8. PubMed ID: 9652181
[TBL] [Abstract][Full Text] [Related]
16. Antithrombin deficiency after prolonged asparaginase treatment in children with acute lymphoblastic leukemia.
Ranta S; Heyman MM; Jahnukainen K; Taskinen M; Saarinen-Pihkala UM; Frisk T; Söderhäll S; Petrini P; Mäkipernaa AM
Blood Coagul Fibrinolysis; 2013 Oct; 24(7):749-56. PubMed ID: 24056293
[TBL] [Abstract][Full Text] [Related]
17. Changes in hypercoagulability by asparaginase: a randomized study between two asparaginases.
Appel IM; Hop WC; Pieters R
Blood Coagul Fibrinolysis; 2006 Mar; 17(2):139-46. PubMed ID: 16479196
[TBL] [Abstract][Full Text] [Related]
18. [Distal coronary thrombosis during L-asparaginase treatment for an acute lymphoblastic leukaemia].
Fraison JB; Calvet P; Domnisoru I; Altamiranda S; Vernhet-Kovacsik H; Saad A; Gallay P; Reny JL; Berdague P
Ann Cardiol Angeiol (Paris); 2012 Aug; 61(4):303-5. PubMed ID: 21663890
[TBL] [Abstract][Full Text] [Related]
19. L-asparaginase-induced coagulopathy in children with acute lymphoblastic leukaemia.
Miniero R; Saracco P; Einaudi S; Garofalo F; Lange MM; Madon E
Drugs Exp Clin Res; 1987; 13(6):377-9. PubMed ID: 3477418
[TBL] [Abstract][Full Text] [Related]
20. L-Asparaginase lowers plasma antithrombin and mannan-binding-lectin levels: Impact on thrombotic and infectious events in children with acute lymphoblastic leukemia.
Merlen C; Bonnefoy A; Wagner E; Dedeken L; Leclerc JM; Laverdière C; Rivard GE
Pediatr Blood Cancer; 2015 Aug; 62(8):1381-7. PubMed ID: 25820776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
